Prenetics is a pioneering genomics-driven health sciences brand that is revolutionizing the fields of prevention, early detection, and treatment. With a mission to enhance life through science, Prenetics offers a wide range of products and services tailored to empower individuals to take control of their own health. Led by a team of experienced industry professionals, including Co-Founder and CEO Danny Yeung, Prenetics has quickly gained recognition as a global health company.

Their comprehensive offerings include genetic testing, molecular diagnostics, and laboratory automation. Utilizing cutting-edge technologies like microarray and biochip-based genotyping platforms, Prenetics enables in-depth profiling of various health conditions such as cancer and drug resistance. Additionally, they provide next-generation sequencing technologies for the detection of neurological diseases and rare genetic variants.

By combining scientific expertise with consumer-focused innovation, Prenetics is transforming the landscape of healthcare. Their commitment to excellence and dedication to improving lives make them a trusted and influential brand in the industry